Skip to content
10-Q

Quarterly Report

Q Therapeutics, Inc.

0001193125-14-289872

← back to feed
Filed
Jul 31, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Jul 31, 2014 30.3M sh
Stockholders Equity Q2 2014 · Jun 30, 2014 $591.96K
Stockholders Equity Q2 2014 · Dec 31, 2013 −$3.04M
Current Liabilities Q2 2014 · Jun 30, 2014 $1.35M
Current Liabilities Q2 2014 · Dec 31, 2013 $3.3M
Current Assets Q2 2014 · Jun 30, 2014 $1.91M
Current Assets Q2 2014 · Dec 31, 2013 $221.53K
Total Assets Q2 2014 · Jun 30, 2014 $1.94M
Total Assets Q2 2014 · Dec 31, 2013 $257.04K
Revenue Q2 2014 · Jun 30, 2014 $502.62K
Revenue Q2 2014 · Jun 30, 2014 $502.62K
Revenue Q2 2014 · Jun 30, 2013 $6.79K
Revenue Q2 2014 · Jun 30, 2013 $12.29K
Capex Q2 2014 · Jun 30, 2013 $22.36K
Operating Cash Flow Q2 2014 · Jun 30, 2013 −$424.07K
Cash And Equivalents Q2 2014 · Jun 30, 2013 $347.79K
Cash And Equivalents Q2 2014 · Dec 31, 2012 $794.21K
Sga Expense Q2 2014 · Jun 30, 2013 $376.87K
Sga Expense Q2 2014 · Jun 30, 2013 $751.59K
Rd Expense Q2 2014 · Jun 30, 2013 $139.84K
Rd Expense Q2 2014 · Jun 30, 2013 $270.95K
Net Income Q2 2014 · Jun 30, 2013 −$509.73K
Net Income Q2 2014 · Jun 30, 2013 −$1.01M
Operating Income Q2 2014 · Jun 30, 2013 −$509.92K
Operating Income Q2 2014 · Jun 30, 2013 −$1.01M
Gross Profit Q2 2014 · Jun 30, 2013 $6.79K
Gross Profit Q2 2014 · Jun 30, 2013 $12.29K